ID   PGM2L_HUMAN             Reviewed;         622 AA.
AC   Q6PCE3; Q96MQ7; Q9UIK3;
DT   19-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   10-MAY-2017, entry version 126.
DE   RecName: Full=Glucose 1,6-bisphosphate synthase;
DE            EC=2.7.1.106;
DE   AltName: Full=PMMLP;
DE   AltName: Full=Phosphoglucomutase-2-like 1;
GN   Name=PGM2L1; Synonyms=BM32A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RA   Mori K., Miyoshi Y., Nakamura Y.;
RL   Submitted (OCT-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ILE-531.
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS PRO-14 AND
RP   ILE-531.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=17804405; DOI=10.1074/jbc.M706818200;
RA   Maliekal P., Sokolova T., Vertommen D., Veiga-da-Cunha M.,
RA   Van Schaftingen E.;
RT   "Molecular identification of mammalian phosphopentomutase and glucose-
RT   1,6-bisphosphate synthase, two members of the alpha-D-
RT   phosphohexomutase family.";
RL   J. Biol. Chem. 282:31844-31851(2007).
RN   [6]
RP   FUNCTION.
RX   PubMed=18927083; DOI=10.1074/jbc.M805224200;
RA   Veiga-da-Cunha M., Vleugels W., Maliekal P., Matthijs G.,
RA   Van Schaftingen E.;
RT   "Mammalian phosphomannomutase PMM1 is the brain IMP-sensitive glucose-
RT   1,6-bisphosphatase.";
RL   J. Biol. Chem. 283:33988-33993(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-175, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-175, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-175, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-175, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Glucose 1,6-bisphosphate synthase using 1,3-
CC       bisphosphoglycerate as a phosphate donor and a series of 1-
CC       phosphate sugars as acceptors, including glucose 1-phosphate,
CC       mannose 1-phosphate, ribose 1-phosphate and deoxyribose 1-
CC       phosphate. 5 or 6-phosphosugars are bad substrates, with the
CC       exception of glucose 6-phosphate. Also synthesizes ribose 1,5-
CC       bisphosphate. Has only low phosphopentomutase and
CC       phosphoglucomutase activities. {ECO:0000269|PubMed:17804405,
CC       ECO:0000269|PubMed:18927083}.
CC   -!- CATALYTIC ACTIVITY: 3-phospho-D-glyceroyl phosphate + alpha-D-
CC       glucose 1-phosphate = 3-phospho-D-glycerate + alpha-D-glucose 1,6-
CC       bisphosphate.
CC   -!- SIMILARITY: Belongs to the phosphohexose mutase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB019210; BAA82756.1; -; mRNA.
DR   EMBL; AK056591; BAB71227.1; -; mRNA.
DR   EMBL; AP001085; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC059360; AAH59360.1; -; mRNA.
DR   CCDS; CCDS8231.1; -.
DR   RefSeq; NP_775853.2; NM_173582.4.
DR   UniGene; Hs.26612; -.
DR   ProteinModelPortal; Q6PCE3; -.
DR   BioGrid; 129496; 8.
DR   IntAct; Q6PCE3; 4.
DR   STRING; 9606.ENSP00000298198; -.
DR   iPTMnet; Q6PCE3; -.
DR   PhosphoSitePlus; Q6PCE3; -.
DR   BioMuta; PGM2L1; -.
DR   DMDM; 317373530; -.
DR   EPD; Q6PCE3; -.
DR   MaxQB; Q6PCE3; -.
DR   PaxDb; Q6PCE3; -.
DR   PeptideAtlas; Q6PCE3; -.
DR   PRIDE; Q6PCE3; -.
DR   DNASU; 283209; -.
DR   Ensembl; ENST00000298198; ENSP00000298198; ENSG00000165434.
DR   GeneID; 283209; -.
DR   KEGG; hsa:283209; -.
DR   UCSC; uc001ovb.2; human.
DR   CTD; 283209; -.
DR   GeneCards; PGM2L1; -.
DR   HGNC; HGNC:20898; PGM2L1.
DR   HPA; HPA056995; -.
DR   HPA; HPA060948; -.
DR   MIM; 611610; gene.
DR   neXtProt; NX_Q6PCE3; -.
DR   OpenTargets; ENSG00000165434; -.
DR   PharmGKB; PA134938366; -.
DR   eggNOG; KOG1220; Eukaryota.
DR   eggNOG; COG1109; LUCA.
DR   GeneTree; ENSGT00390000017247; -.
DR   HOGENOM; HOG000268676; -.
DR   HOVERGEN; HBG056917; -.
DR   InParanoid; Q6PCE3; -.
DR   KO; K11809; -.
DR   OMA; GRCPISF; -.
DR   OrthoDB; EOG091G040C; -.
DR   PhylomeDB; Q6PCE3; -.
DR   TreeFam; TF300692; -.
DR   ChiTaRS; PGM2L1; human.
DR   GenomeRNAi; 283209; -.
DR   PRO; PR:Q6PCE3; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000165434; -.
DR   CleanEx; HS_PGM2L1; -.
DR   Genevisible; Q6PCE3; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0047933; F:glucose-1,6-bisphosphate synthase activity; IDA:UniProtKB.
DR   GO; GO:0016868; F:intramolecular transferase activity, phosphotransferases; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006006; P:glucose metabolic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.310.50; -; 1.
DR   InterPro; IPR005844; A-D-PHexomutase_a/b/a-I.
DR   InterPro; IPR016055; A-D-PHexomutase_a/b/a-I/II/III.
DR   InterPro; IPR005845; A-D-PHexomutase_a/b/a-II.
DR   InterPro; IPR005846; A-D-PHexomutase_a/b/a-III.
DR   InterPro; IPR005843; A-D-PHexomutase_C.
DR   Pfam; PF02878; PGM_PMM_I; 1.
DR   Pfam; PF02879; PGM_PMM_II; 1.
DR   Pfam; PF02880; PGM_PMM_III; 1.
DR   Pfam; PF00408; PGM_PMM_IV; 1.
DR   SUPFAM; SSF53738; SSF53738; 3.
DR   SUPFAM; SSF55957; SSF55957; 1.
PE   1: Evidence at protein level;
KW   Carbohydrate metabolism; Complete proteome; Glucose metabolism;
KW   Isomerase; Magnesium; Metal-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transferase.
FT   CHAIN         1    622       Glucose 1,6-bisphosphate synthase.
FT                                /FTId=PRO_0000147784.
FT   REGION      175    176       Substrate binding.
FT                                {ECO:0000250|UniProtKB:P00949}.
FT   REGION      336    337       Substrate binding.
FT                                {ECO:0000250|UniProtKB:P00949}.
FT   REGION      434    436       Substrate binding.
FT                                {ECO:0000250|UniProtKB:P00949}.
FT   ACT_SITE    175    175       Phosphoserine intermediate.
FT                                {ECO:0000250|UniProtKB:P00949}.
FT   METAL       175    175       Magnesium; via phosphate group.
FT                                {ECO:0000250|UniProtKB:P00949}.
FT   METAL       332    332       Magnesium.
FT                                {ECO:0000250|UniProtKB:P00949}.
FT   METAL       334    334       Magnesium.
FT                                {ECO:0000250|UniProtKB:P00949}.
FT   METAL       336    336       Magnesium.
FT                                {ECO:0000250|UniProtKB:P00949}.
FT   BINDING      69     69       Substrate.
FT                                {ECO:0000250|UniProtKB:P00949}.
FT   BINDING      73     73       Substrate.
FT                                {ECO:0000250|UniProtKB:P00949}.
FT   BINDING     448    448       Substrate.
FT                                {ECO:0000250|UniProtKB:P00949}.
FT   MOD_RES     175    175       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   VARIANT      14     14       L -> P (in dbSNP:rs12049823).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_028094.
FT   VARIANT     531    531       V -> I (in dbSNP:rs592644).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_028095.
FT   VARIANT     608    608       N -> I (in dbSNP:rs36014178).
FT                                /FTId=VAR_056665.
FT   CONFLICT     69     69       T -> A (in Ref. 2; BAB71227).
FT                                {ECO:0000305}.
SQ   SEQUENCE   622 AA;  70442 MW;  8AE00403B5D973CA CRC64;
     MAENTEGDLN SNLLHAPYHT GDPQLDTAIG QWLRWDKNPK TKEQIENLLR NGMNKELRDR
     LCCRMTFGTA GLRSAMGAGF CYINDLTVIQ STQGMYKYLE RCFSDFKQRG FVVGYDTRGQ
     VTSSCSSQRL AKLTAAVLLA KDVPVYLFSR YVPTPFVPYA VQKLKAVAGV MITASHNRKE
     DNGYKVYWET GAQITSPHDK EILKCIEECV EPWNGSWNDN LVDTSPLKRD PLQDICRRYM
     EDLKKICFYR ELNSKTTLKF VHTSFHGVGH DYVQLAFKVF GFKPPIPVPE QKDPDPDFST
     VKCPNPEEGE SVLELSLRLA EKENARVVLA TDPDADRLAA AELQENGCWK VFTGNELAAL
     FGWWMFDCWK KNKSRNADVK NVYMLATTVS SKILKAIALK EGFHFEETLP GFKWIGSRII
     DLLENGKEVL FAFEESIGFL CGTSVLDKDG VSAAVVVAEM ASYLETMNIT LKQQLVKVYE
     KYGYHISKTS YFLCYEPPTI KSIFERLRNF DSPKEYPKFC GTFAILHVRD VTTGYDSSQP
     NKKSVLPVSK NSQMITFTFQ NGCVATLRTS GTEPKIKYYA EMCASPDQSD TALLEEELKK
     LIDALIENFL QPSKNGLIWR SV
//
